Buzz Stocks: Best Buy, Syngenta, Acorda Therapeutics

Today's stocks to watch include Best Buy Co Inc (BBY), Syngenta AG (ADR) (SYT), and Acorda Therapeutics Inc (ACOR)

Aug 25, 2015 at 9:29 AM
facebook twitter linkedin


After yesterday's nearly 600-point drop, the Dow is poised to recoup some of the losses -- so remember, keep your hands inside the cart at all times and please enjoy the ride. Among the equities in focus are electronics retailer Best Buy Co Inc (NYSE:BBY), agribusiness company Syngenta AG (ADR) (NYSE:SYT), and biopharmaceutical concern Acorda Therapeutics Inc (NASDAQ:ACOR).

  • A surprise quarterly profit has propelled BBY more than 13% higher in electronic trading. Best Buy Co Inc saw second-quarter profit increase 12% (subscription required), as strong sales from large-screen TVs, appliances, and telephones offset weak tablet sales. A short-covering pop could boost the stock even higher, as 10% of BBY's float is sold short. At BBY's average pace of trading, it would take nearly eight sessions to buy back these bearish bets. On Monday, BBY closed at $29.27.

  • SYT sat out yesterday's broad-market pullback, jumping to $81.37. What's more, the stock is nearly 3% higher in pre-market trading, after Monsanto Company (NYSE:MON) reportedly upped its takeover offer for the chemical maker. MON is now allegedly offering $47 billion for Syngenta AG (ADR). While MON continues to try and takeover the chemical world, SYT is refusing to comment. Technically, SYT has seen its share of struggles, but near-term option players are more call-heavy than usual. SYT's Schaeffer's put/call open interest ratio (SOIR) of 0.18 is lower than 99% of the readings taken during the past 52 weeks.  

  • ACOR is set to start the morning more than 22% higher, after the U.S. Patent and Trademark Office ruled against patent challenges leveled by hedge fund manager Kyle Bass. Acorda Therapeutics Inc has been backing away from its 10-day moving average, which has pushed the shares lower since the beginning of the month. However, ACOR is set to take out this trendline -- and rebound from yesterday's annual low -- out of the gate today. The shares could benefit from a short-covering rally, as 15% of ACOR's float is sold short, representing 15 days of pent-up buying demand, at the equity's average pace of trading. ACOR settled at $28.96 yesterday.

Get the skinny on all the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earnings guide for Q3 before it's too late!


  
 
Special Offers from Schaeffer's Trading Partners